Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. Februar 2020 08:15 ET | Quelle: Novan, Inc.

Novan Receives Phase 2 NIH Federal Grant of Approximately $1.0 Million

Provides funds to evaluate the mechanistic antiviral activity of WH602Novan to progress IND-enabling toxicology and pharmacology studies for WH602 Grant is additive to $223,000 Phase 1 NIH grant...
20. September 2019 08:30 ET | Quelle: Novan, Inc.

Novan Awarded Approximately $1.1 Million Grant by Department of Defense

Funds to progress women’s health product candidate, WH504Additive to recently announced NIH grant for WH602Women’s health initiative to focus on potential HPV related onco-virus therapeutics ...
14. August 2019 08:15 ET | Quelle: Novan, Inc.

Novan Advances Women’s Health Business Unit with Non-Dilutive Funding

Company has received NIH federal grant of approximately $223,000Anticipates additional federal grant of approximately $1.0 millionWomen’s health initiative to focus on potential HPV related onco-virus...
25. Oktober 2018 07:05 ET | Quelle: Novan, Inc.

Novan Creates Dedicated Women’s Health Business Unit

Business unit will focus on Novan’s proprietary nitric oxide technology and its application to target high-risk human papillomavirus (HPV) and associated cancers affecting women such as cervical...